Drug intelligence / Profile preview

PBI-04711

Development stage
Preclinical
Lead developer
Phoenix Biotechnology
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01

Overview

PBI-04711 is a first-generation botanical extract developed by Phoenix Biotechnology, Inc. Derived from the oleander plant (*Nerium oleander*), it is uniquely processed to be free of cardiac glycosides, specifically excluding oleandrin to mitigate potential cardiotoxicity. The extract contains a concentrated mixture of oleander-derived triterpenes and is being investigated for its neuroprotective properties. Preclinical research suggests potential utility in treating neurodegenerative conditions by leveraging the bioactivity of triterpenoids without the narrow therapeutic index associated with traditional oleander extracts.

Other names
oleander-derived triterpene extractcardiac glycoside-free oleander extract

Beyond the preview

Go deeper on PBI-04711.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PBI-04711.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call